- 10 mg - Adefovir Dipivoxil
Without a Prescription
Adefovir is prescribed for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either
evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
Adefovir indication is based on:
responses in adult patients with HBeAg+ and HBeAg- chronic hepatitis B with compensated liver function, and in adult patients
with clinical evidence of lamivudine-resistant hepatitis B virus with either compensated or decompensated liver function.
For patients 12-18 years of age, the indication of Adefovir is based on virological and biochemical responses in patients with
HBeAg+ chronic hepatitis B virus infection with compensated liver function.
Chronic Hepatitis B:
Adefovir recommended dose in chronic hepatitis B patients for patients >12 years of age with adequate renal function is 10 mg,
once daily, taken orally, without regard to food. The optimal duration of treatment is unknown.
Adefovir is not recommended for use in children less than 12 years of age.
Adjustment in Renal Impairment:
Significantly increased drug exposures were seen when Adefovir dipivoxil was administered to patients with renal
impairment. Therefore, the dosing interval of Adefovir should be adjusted in patients with baseline creatinine clearance <50 mL/min using the following suggested guidelines ( Table 2).The safety and effectiveness of these dosing interval adjustment guidelines have not been clinically evaluated.
Additionally, Adefovir is important to note that these guidelines were derived from data in patients with pre-existing
renal impairment at baseline. They may not be appropriate for patients in whom renal insufficiency evolves during treatment
with Adefovir. Therefore, clinical response to treatment and renal function should be closely monitored in these patients.
Adefovir is contraindicated in patients with previously demonstrated hypersensitivity to any of the components of the product.
Container of 30 Tablets